Vella Bioscience
PrivateLast Round
Accelerator
Mar 26, 2025
Est. Valuation
$45M
Total Funding Raised
$12M
Company Overview
Vella Bioscience operates in Consumer & Commerce and is based in Tulsa, Oklahoma. Its latest recorded funding round was an Accelerator round in March 2025.
Vella Bioscience is a femtech company that manufactures science-backed personal care products designed to support female sexual pleasure and well-being.
Sector
Consumer & Commerce
Verticals
D2C Brands, Fashion & Beauty, Biotechnology
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vella Bioscience Comparables
Compare Vella Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eden Partners LLC | 84% | |
| Rosebud Woman | 79% | |
| Dame Products | 78% |
For institutional investors. Book with your work email.
Vella Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 26, 2025 | ||||
| Seed | Apr 17, 2023 | ||||
| Seed | May 13, 2021 |
For institutional investors. Book with your work email.
Vella Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Springboard Enterprises | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Pleasurewave(TM) brings precision to CBD.
- Mar 24, 2026
Everslide has been launched as part of a strategic product line reintroduction.
For institutional investors. Book with your work email.
Vella Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vella Bioscience's valuation, stock price, and market status.
Is Vella Bioscience a public or private company?
Vella Bioscience is a private company.
What is the current stock price of Vella Bioscience?
Vella Bioscience is a private company, so its shares have no public market price. Caplight tracks Vella Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vella Bioscience worth (valuation)?
Vella Bioscience's valuation is estimated at $45.0M based on funding round data.
Can I buy Vella Bioscience stock?
Vella Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vella Bioscience's last funding round?
Vella Bioscience's most recent funding round was Accelerator on March 26, 2025.
Who are the main investors in Vella Bioscience?
Key investors in Vella Bioscience include Springboard Enterprises.
Will Vella Bioscience IPO soon?
No public IPO plans have been announced for Vella Bioscience.
How can I track Vella Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Vella Bioscience's shares on secondary markets.